Nilotinib, sold under the brand name Tasigna marketed worldwide by Novartis, is a medication used to treat chronic myelogenous leukemia (CML) which has the Philadelphia chromosome. It may be used both in initial cases of chronic phase CML as well as in accelerated and chronic phase CML that has not responded to imatinib. It is taken by mouth. Nilotinib was approved for medical use in the United States in 2007. It is on the World Health Organization’s List of Essential Medicines.
Are you looking for or in search of FDA approved “Nilotinib Capsules in India”? “Medicant Healthcare” a registered pharmacy firm in India deals in both brand name as well as generic name Drugs / medicine approved for Leukemia treatment. Need Access of “Nilotinib Capsules, get in touch with our healthcare professional.
Nilotinib is approved to treat: Chronic myelogenous leukemia (CML) that is Philadelphia chromosome positive.